Skip to main content

Day: November 29, 2024

Form 8.3 – [LOUNGERS PLC – Opening Disclosure – 28 11 2024] – (CGAML)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Form 8.3 – [LOUNGERS PLC – Opening Disclosure – 28 11 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [VOLEX PLC – 28 11 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree VOLEX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Invesco Ltd: Form 8.3 – Aviva PLC; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Aviva PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to the...

Continue reading

SSCP Lager Bidco AB (publ) – Interim report for third quarter 2024

SSCP Lager Bidco AB (publ) – Interim report for third quarter 2024 Date: 29th of November 2024SSCP Lager BidCo AB (publ) – Interim report for the period 1 July – 30 September 2024. Today SSCP Lager Bidco AB (publ) published the interim report for the third quarter, the report can be downloaded on www.logent.se or via the link below. For more information, please contact:Andrzej Kulik, CFO, telephone number: +46 73 8 15 67 00, andrzej.kulik@logent.se or Linda Aidanpää Baronnet, CEO, telephone number: +46 70 785 87 25, linda.aidanpaa@logent.se This press release was published on 29th of November at CET 15:30 This information is information that SSCP Lager BidCo AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above,...

Continue reading

Narayana Health Issues Statement Regarding Spire Healthcare Group plc Under Rule 2.8 of the Takeover Code

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE “CODE”). BANGALORE, India, Nov. 29, 2024 (GLOBE NEWSWIRE) — Statement regarding Spire Healthcare Group plc (“Spire”) In response to recent media speculation, Narayana Health confirms that it does not intend to make an offer for Spire. This is a statement to which Rule 2.8 of the Code applies. Accordingly, Narayana Health (and any person acting in concert with it) is, except in the circumstances set out below or otherwise with the consent of the the Panel on Takeovers and Mergers (the “Panel”), bound by the restrictions...

Continue reading

Interim Report for the period January 1 – September 30, 2024

Nasdaq OMX Copenhagen A/S Charlottenlund November 29, 2024 Announcement no. 269 Interim Report for the period January 1 – September 30, 2024 The Board of Directors has today reviewed and adopted the attached interim report for the period January 1 – September 30, 2024The result before value adjustments and tax for the period January 1 – September 30, 2024, showed a profit of T.EUR 51.0. The result is considered as expected.Although the required rate of return in Q3 2024 appears to be slightly decreasing, management maintains unchanged the assessment as of September 30, 2024, of the fair market value of the investment properties of EUR 89.5 million, which is unchanged since June 30, 2024.In connection with the company’s capital increase carried out in Q3 2024, as per stock exchange announcement no. 267 dated September 24, 2024,...

Continue reading

Invesco Ltd: Form 8.3 – Loungers PLC; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Loungers PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Continue reading

Invesco Ltd: Form 8.3 – Direct Line Insurance Group PLC; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Direct Line Insurance Group PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable...

Continue reading

Medical Robots Market to Witness Massive Growth at USD 34.32 Billion by 2031 | SkyQuest Technology

Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the medical robot market will attain a value of USD 34.32 Billion by 2031, with a CAGR of 17.4 % during the forecast period (2024-2031). The rising incidence of diseases such as cancer, neurological disorders, and orthopedic neck & spine conditions will create demand for accuracy surgical procedures particularly in the aging population segment, fueling medical robots market growth. Increasing numbers of geriatric patients undergoing surgical procedures also boosts market growth. Ideal for patients and healthcare professionals alike, robotic surgical procedures offer better advantages over traditional open surgeries that can include less pain, shorter recovery times, and decreased complication rates. Compared to traditional techniques, robotic systems provide...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.